Award
Definitive Contract #75F40126C00059
University of Connecticut Awarded Definitive Contract for LNG-IUS Development
Buyer
Food and Drug Administration
Award Amount
$511,219.00
Ceiling
$789,844.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2028
Identifier
75F40126C00059
NAICS
541714
This definitive contract has been awarded to the University of Connecticut to support the advancement of levonorgestrel intrauterine systems (LNG-IUS). The University, a prominent research institution, will undertake comprehensive development, evaluation, and predictive modeling activities involving innovative accelerated testing methods, real-time release studies, microstructural analysis, and AI/ML-driven modeling approaches. This multi-year contract aims to enhance contraceptive technology through sophisticated integration of scientific and computational techniques. The work will be performed primarily in Silver Spring, Maryland, and is planned over an initial two-year period with an option to extend for an additional year. The award was competitively acquired to ensure robust research outcomes, reflecting its significance to public health and medical innovation. No subcontractors or related acquisition programs were indicated, and this contract represents a standalone effort in the advancement of LNG-IUS technologies.
Description
TO ADVANCE THE DEVELOPMENT, EVALUATION, AND PREDICTIVE MODELING OF LEVONORGESTREL INTRAUTERINE SYSTEMS (LNG-IUSS) BY INTEGRATING ACCELERATED TESTING, REAL-TIME RELEASE STUDIES, MICROSTRUCTURAL ANALYSIS, AND AI/ML-DRIVEN MODELING APPROACHES.